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Abstract
Background: Hip fracture patients are frail and have a high mortality. We investigated whether the introduction of
fast track care reduced the 30-day mortality after hip fractures.
Methods: Fast track hip fracture care was established at our institution in October 2013. Data from the Norwegian
Hip Fracture Register and electronic hospital records were merged for 2230 hip fracture patients operated in our
department from January 2012 through December 2015. 1090 of these patients were operated before
(conventional treatment group) and 1140 patients were operated after the introduction of fast track care (fast track
group). Data were analysed by univariate analysis and binary logistic regression.
Results: Mortality did not differ significantly between the conventional treatment group and the fast track group at
30 days (7.9% vs. 6.5%), 90 days (13.5% vs. 12.5%) and one year (22.8% vs. 22.8%). Median admission time and time
to surgery were significantly shorter in the fast track group than in the conventional treatment group (1.1 h vs. 3.9 h
and 23.6 h vs. 25.7 h, both p < 0.0001). The 30-day reoperation rate was significantly lower in the fast track group
compared to the conventional treatment group (odds ratio = 0.35 (95% CI: 0.15–0.84), p = 0.019). A composite 30-
day outcome (reoperation, surgical site infection and/or death) was significantly less frequent in the fast track group
(8.1%) than in the conventional treatment group (10.7%) in unadjusted analysis (p = 0.006), but not after adjusting
for age, gender, cognitive impairment and ASA score (odds ratio = 0.85 (95% CI: 0.63–1.16), p = 0.31, 8.0% missing).
Reoperations within 1 year, surgical site infections, 30-day readmissions and length of hospital stay did not differ
significantly between the conventional treatment group and the fast track group.
Conclusions: Fast track hip fracture care is safe. However, we observed no statistically significant change in 30-day,
90-day or 1-year mortality after the introduction of fast track hip fracture care.
Trial registration: The study was registered retrospectively at ClinicalTrials.gov (Protocol Record 284907)
6 December 2016.
Keywords: Hip fracture, Fast track, Mortality, Reoperation, Surgical site infection, Admission time, Time to surgery,
Length of stay, Readmission, Norwegian hip fracture register
Background
Hip fracture patients represent one of the largest groups
of patients in orthopaedic surgery. A hip fracture consti-
tutes a serious injury for these typically frail and elderly
patients. This is reflected in several studies reporting
high mortality rates between 6 and 11% within 30 days
[1–4] and between 20 and 30% within 1 year [2, 5, 6]. In
addition to the individual fate, hip fractures pose a
growing public health problem. Due to the increasing
age of the population in the western world the hip frac-
ture burden is predicted to increase substantially over
the next decades [7].
Traditionally, orthopaedic research has focused on sur-
gical techniques for the treatment of hip fractures [8, 9].
However, excess mortality after a hip fracture remains
high [5, 10]. Therefore, a new approach is warranted to
try to reduce the high mortality. One such approach is
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the development of standardized fast track care systems
for hip fracture patients.
Fast track methodology refers to a comprehensive
treatment concept for surgical patients which takes into
account the patients’ co-morbidities, cognitive impair-
ment and polypharmacy, and which focuses on stress re-
duction, opioid sparing pain relief, nutrition and early
mobilization to promote postoperative recovery [11].
Fast track patient care was initially developed for elective
abdominal surgery [11], but the principles have subse-
quently been applied to elective orthopaedic surgery
with good results [12]. More recently, fast track care sys-
tems have also been reported for hip fracture patients
[13–17]. However, the effect on mortality is unclear.
While one study reported lower 1-year mortality in
community dwellers [18] several other studies found no
effect of fast track care on mortality in hip fracture
patients [14–17, 19].
The primary aim of this study was to investigate if the
introduction of fast track care at our institution reduced
the 30-day mortality rate after hip fracture surgery.
Secondary outcome measures were 90-day and 1-year
mortality, any cause reoperation, surgical site infection, a
composite 30-day outcome (reoperation, surgical site in-
fection or death), admission time, time to surgery, length
of hospital stay and 30-day readmission.
Methods
This study is reported according to the REporting of stud-
ies Conducted using Observational Routinely-collected
health Data (RECORD) Statement [20].
Conventional hip fracture care
Patients with suspected hip fracture were admitted via the
accident and emergency (A&E) department, Akershus
university hospital (AHUS). The patients had to wait for
an available examination room, an available physician and
a slot in the radiology lab. After x-ray examination the pa-
tients were transported back to the A&E department
where the admitting physician evaluated the x-rays and
finished the work-up before the patient was transported to
the orthopaedic ward.
Apart from antithrombotic and perioperative antibiotic
prophylaxis, perioperative treatment was not standard-
ized. There was no systematic focus on nutritional status
and on prevention and treatment of delirium. The
patients were not consistently mobilized on the first
postoperative day.
Fast track hip fracture care
Fast track hip fracture care was introduced at AHUS
in two steps. From 28 October 2013, guidelines
concerning perioperative treatment were taken into
practice. Secondly, 27 January 2014, the fast track
pathway for hospital admission was implemented.
The ambulance personnel initiate first line treatment
(intravenous fluids, oxygen, pain relief and electrocardio-
gram). Upon arrival at the A&E department a trained
nurse triages all suspected hip fracture patients using
the Manchester triage system [21]. If deemed necessary,
additional intravenous opiates are administered in
selected cases.
Patients without signs of other, more acute medical
conditions (score of 3 or higher) continue in the fast
track admission pathway if they fulfil the following
criteria: Low energy trauma, hip/groin pain, shortened
and/or externally rotated lower extremity and/or unable
to bear weight, no sign of other fractures, no sign of
neurovascular injury, not previously operated on the hip
in question.
From the triage area the patient is brought directly to
the radiology lab where fast track hip fracture patients
are prioritized after any ongoing procedure.
The radiology technician evaluates the x-ray. If consid-
ered to have a hip fracture the patient is transported dir-
ectly to the orthopaedic ward where a nurse performs
standard procedures according to a check-list and gives
the patient both oral and written information about hip
fractures and the expected course of treatment.
The orthopaedic surgeon re-evaluates the x-ray, writes
an admission note, administers a fascia iliaca compart-
ment block and prescribes a set of standard medications,
including oral and intravenous fluids and pain medication.
The fast track hip fracture care system includes
written guidelines concerning standard blood sampling,
premedication, pre- and postoperative pain relief with
focus on opiate sparing, pre- and postoperative fluid
treatment with focus on short periods of fasting,
transfusion-triggers and management of anticoagulants.
Patients are mobilized on the first postoperative day.
The guidelines also advise on screening for and
prevention and treatment of delirium, on screening of
nutritional status and on appropriate interventions
concerning nutrition.
Data collection
All primary and revision hip fracture operations in
Norway should be reported to the Norwegian Hip Frac-
ture Register (NHFR) [22]. This is done prospectively by
the surgeon on a 1-page questionnaire which includes
information on the type of fracture, American Society of
Anaesthesiologists (ASA) score [23], cognitive impair-
ment (possible choices: ‘no’, ‘uncertain’, ‘yes’), type of
anaesthesia, type of operation, surgeon’s experience (at
least one surgeon with > 3 years of experience in hip
fracture surgery) and operating time (time from incision
to skin closure).
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We obtained the NHFR data for patients operated at
AHUS from January 2012 through December 2015. For
the same time period, hip fracture patients were identi-
fied from the electronic hospital records using the search
strings main diagnosis S72.0, S72.1 or S72.2 (ICD-10),
in-patient, operated during that hospital admission. The
two databases were linked deterministically using the
unique 11-digit Norwegian personal identification num-
ber. For patients who were only identified in one of the
data sources or for whom the records did not match, the
electronic hospital records were scrutinized to determine
if there had occurred an error in coding or in reporting
to the NHFR.
Patients
All patients 18 years of age or older who were operated
for a fracture of the proximal femur (femoral neck,
trochanteric or subtrochanteric) at a single institution
(AHUS) from January 2012 through December 2015
were eligible for inclusion (Fig. 1). AHUS has a catch-
ment area of approximately 500.000 inhabitants.
During the study period 2634 primary hip fracture
operations were performed. For patients who sustained
two hip fractures during the study period (n = 92), only
the first fracture was included in the analysis. Patients
with a pathologic fracture were excluded (n = 47). 265
patients were not reported to the NHFR, corresponding
to an overall reporting rate from AHUS of 89.4% (87.9%
before and 90.8% after the introduction of fast track
hip fracture care). The remaining 2230 patients, who
were reported to the NHFR, represent the study
population. Of these 1090 patients were operated
before (conventional treatment group) and 1140
patients were operated after the introduction of fast
track hip fracture care (fast track group) with 28 Oc-
tober 2013 as cut-off. The available data do not allow
us to determine to what extent the different compo-
nents of the reported fast track care system were
applied to an individual patient. Therefore, the
analysis follows the intention to treat principle and
hip fracture patients treated from 28 October 2013
and onwards are included in the fast track group,
irrespective of length of admission time or other
criteria.
Operative treatment
Patients with a femoral neck fracture were treated either
with closed reduction and internal fixation with two
screws, with a cemented bipolar hemiarthroplasty or
with a cemented total hip arthroplasty, both with a taper
slip stem using a direct lateral approach. Trochanteric
fractures were treated with a sliding hip screw and
subtrochanteric fractures with an intramedullary nail.
Surgical treatment guidelines did not differ before and
after the introduction of fast track hip fracture care.
Outcome measures
Mortality
Mortality data from the Central Population Register are
routinely imported to the electronic hospital records and
a last up-date of the database was performed on 14
September 2017 to allow for a delay in registration.
There was no loss to follow-up. 30-day, 90-day and
Fig. 1 Flow chart of patient inclusion. aNorwegian Hip Fracture Register
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1-year mortality were calculated from time of arrival at
the hospital. Survival was censored at 1 year.
Reoperations
Data on reoperations were obtained from the NHFR.
Time to event was calculated from the index operation.
In 2013 and 2014 the reporting rate from our institution
was 66% for reoperations after osteosynthesis and 81.6%
for reoperations after hemiarthroplasty [24].
Surgical site infection
The Department of Microbiology and Infection Control,
AHUS, surveys surgical site infections after hemiarthro-
plasty and total arthroplasty of the hip under the
Norwegian Surveillance System for Antibiotic Use and
Hospital-Acquired Infections (NOIS) [25] with 30-day
and one-year follow-up. Sliding hip screws are not moni-
tored by NOIS, but the Department of Microbiology and
Infection Control, AHUS, surveys surgical site infection
also in these patients with a 30-day follow-up using the
same criteria. The completeness of the 30-day follow-up
ranged from 97.7 to 99.6% per calendar year. The
completeness of the 1-year follow-up ranged from 98.7
to 99.5% for hemiarthroplasties and from 87.6 to 91.9%
for total hip arthroplasties.
Internal fixations of femoral neck fractures and
intramedullary nails are not systematically surveyed for
surgical site infection.
Time to event was calculated from the time of the
index operation.
Composite 30-day outcome
A patient was considered to have had this (negative) out-
come if any of the following had occurred: death within
30-days from arrival at the hospital, reoperation or infec-
tion within 30-days from the index operation.
Readmission
Readmission was defined as any cause, non-elective
readmission within 30 days after discharge from the
index admission. These data were extracted from the
electronic hospital records.
Admission time, time to surgery and length of hospital stay
Admission time (time from arrival at the hospital to
arrival at the orthopaedic ward), time to surgery (time
from arrival at the hospital to skin incision) and length
of hospital stay were extracted from the electronic
hospital records.
Statistical analysis
A sample size calculation based on a reduction of the
30-day mortality rate after hip fracture from 10.7%
(AHUS in 2011 [26]) to 6.8% (hospital with lowest
mortality rate in Norway in 2011 [26]), 85% power and a
level of significance of 0.05 yielded a total sample size of
approximately 1800 patients [27].
Fisher’s exact test was used for unadjusted compari-
sons of proportions, while the Chi square test was used
for unadjusted comparisons of ordinal and nominal
distributions. Student’s T test was used for unadjusted
comparisons of continuous variables. However, compari-
sons of admission times, time to surgery and length of
hospital stay were made with non-parametric
Mann-Whitney U tests, rather than t-tests, due to the
skewed distributions of these variables.
Logistic regression was used to analyze the effects
of different predictors on the binary outcomes of
mortality at 30 days, 90 days and 1 year follow-up,
reoperation and surgical site infections at 30 days and
1 year follow-up, as well as 30-day readmission and
the composite 30-day outcome. The main predictor of
interest in these models was the conventional treat-
ment/fast track care indicator. Other variables were
included as confounders if they showed statistical
significance at the 0.05 level, except for patient age
and gender, which were always included. All munici-
palities and Oslo districts belonging to AHUS’ catch-
ment area were included in the analysis with a
distinct identifier while patients from outside our
hospital’s catchment area were coded as one group.
This variable was considered as a random effect in
the models, but turned out not to have a significant
effect. Reducing time to surgery is one of the
intended effects of fast track care. Therefore, the lo-
gistic regression model analyzing the effect of fast
track care on mortality was run with and without in-
cluding time to surgery as an independent predictor.
This did not relevantly change the result for the
effect of fast track care on mortality.
Survival analysis by Cox regression was considered for
the binary outcomes, since these were all associated with
event times. However, there were problems with the
assumptions of proportional hazards, measured by
Schoenfeld residuals ph-test. Concerning mortality there
was no loss to follow-up, so the logistic regression
models’ inability to handle right-censoring was not an
issue. Also, the standard quality indicators of hip surgery
are defined as the number of adverse outcomes after 30
days, 90 days and 1 year, which is in line with logistic
regression. Logistic regression was therefore chosen.
A post hoc power analysis was performed using
standard normal distribution approximation.
Subgroup analyses
Patients were divided into two subgroups according to
their comorbidity (ASA score). Frailer patients were
defined by an ASA score ≥ 3.
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Results
Baseline characteristics for the conventional treatment
group and the fast track group are shown in Table 1.
Data on surgical treatment for the conventional
treatment group and the fast track group are shown in
Table 2.
Mortality
30-day, 90-day and 1-year mortality did not differ signifi-
cantly between the conventional treatment group and
the fast track group (Table 3). This was consistent in
both unadjusted and adjusted analyses. In the adjusted
analyses, age, male gender, cognitive impairment and
increasing ASA score were independent predictors of
increased mortality (Table 4) while fast track care, time
to surgery, surgeon’s experience, type of fracture, type of
operation, type of anaesthesia, operating time and muni-
cipality were not.
Fast track hip fracture care had no significant effect on
30-day, 90-day or 1-year mortality in subgroup analyses
of healthier (ASA score ≤ 2) and frailer (ASA score ≥ 3)
patients.
30-day mortality was 10.7% in 2011 [26], before the
start of the study. It decreased to 8.6% in 2012 and 6.7%
in 2013 before the introduction of fast track care and
remained stable in 2014 (6.5%) and 2015 (6.8%) (Fig. 2).
A post hoc power analysis, given the sample size and
the observed 30-day mortality rate of 7.9% in the con-
ventional treatment group, showed that the study had
80% power to detect a decrease of the 30-day mortality
rate to 5.0% in the fast track group with a level of signifi-
cance of 0.05.
Secondary outcome measures
Secondary outcome measures for the conventional
treatment group and the fast track group are presented
in Table 5.
Table 1 Baseline characteristics
Conventional treatment




Agec (years) 79.7 (0.3) 79.6 (0.3) 0.69
Genderd 0.5
Women 740 (67.9) 789 (69.2)
ASAd 0.002
ASA 1 36 (3.4) 27 (2.4)
ASA 2 292 (27.3) 358 (32.1)
ASA 3 609 (56.9) 641 (57.5)
ASA 4 130 (12.1) 85 (7.6)
ASA 5 3 (0.3) 4 (0.4)




No 679 (65.9) 737 (70.2)
Uncertain 102 (9.9) 107 (10.2)
Yes 249 (24.2) 206 (19.6)
Missing 60 (5.5) 90 (7.9)
Type of fractured 0.69
Femoral neck,
undisplaced
171 (15.7) 181 (15.9)
Femoral neck,
displaced
445 (40.9) 439 (38.6)
Basocervical 31 (2.9) 25 (2.2)
Trochanteric, 2
fragments
166 (15.3) 176 (15.5)
Trochanteric, >
2 fragments
169 (15.5) 180 (15.8)
Intertrochanteric 21 (1.9) 27 (2.4)
Subtrochanteric 37 (3.4) 42 (3.7)
Other 47 (4.3) 66 (5.8)
Missing 3 (0.3) 4 (0.4)
aNumber of patients in group
bTest for equal distribution in both groups (Student’s T-test for age, Chi square
test for all other parameters)
cMean (standard error)
dn (%)








Type of operationc 0.25
Hemiarthroplasty 450 (41.3) 434 (38.1)
Screw osteosynthesis 169 (15.5) 193 (16.9)
Sliding hip screw 403 (37.0) 422 (37.0)
Intramedullary nail 29 (2.7) 34 (3.0)
Total hip replacement 38 (3.5) 57 (5.0)
Resectionarthroplasty 1 (0.1) 0 (0)
Missing 0 (0) 0 (0)
Type of anesthesiac 0.002
Spinal 916 (88.6) 912 (85.5)
General 74 (7.2) 122 (11.4)
Other 44 (4.3) 33 (3.1)
Missing 56 (5.1) 73 (6.4)
Surgeon’s experiencec 0.75
≤ 3 years 141 (14.3) 157 (14.9)
> 3 years 842 (85.7) 900 (85.1)
Missing 107 (9.8) 83 (7.3)
Operating timed (min.) 60 (1) 63 (1) 0.003
aNumber of patients in group
bTest for equal distribution in both groups (Student’s T-test for operating time,
Chi square test for all other parameters)
cn (%)
dMean (standard error)
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The 30-day reoperation rate was lower in the fast track
group (0.6%) than in the conventional treatment group
(1.7%) (p = 0.017). After adjusting for age and gender,
fast track hip fracture care remained an independent
predictor of a lower 30-day reoperation rate (OR = 0.35,
(95% CI: 0.15–0.84), p = 0.019, 0% missing).
The composite 30-day outcome (reoperation,
surgical site infection and/or death) was less frequent
in the fast track group (8.1%) compared to the con-
ventional treatment group (10.7%) in an unadjusted
analysis (p = 0.035). However, after adjusting for age,
gender, cognitive impairment and ASA score, the
odds-ratio for fast track care was no longer statistically
significant (OR = 0.85 (95% CI: 0.63–1.16), p = 0.31, 8.0%
missing).
Reoperation within 1 year, surgical site infection and
30-day readmission did not differ significantly between the
conventional treatment group and the fast track group.
Admission time, time to surgery and length of hospital stay
The median time from arrival at the hospital to arrival at
the orthopaedic ward (admission time) and from arrival
at the hospital to the start of surgery was significantly
shorter in the fast track group compared to the conven-
tional treatment group while the median length of
hospital stay did not differ significantly (Table 6).
Discussion
Although the introduction of fast track hip fracture care
significantly reduced admission time, time to surgery
and the risk of reoperation within 30 days, we observed
no significant change in 30-day, 90-day or 1 year mortal-
ity. The composite 30-day outcome (reoperation, surgi-
cal site infection and/or death) was significantly less
frequent in the fast track group in univariate analysis.
However, in multivariate analysis this difference was no
longer significant. There was a numerical trend towards
fewer reoperations within 1 year, fewer surgical site in-
fections and fewer 30-day readmissions in the fast track
group, but this was not statistically significant. The
length of hospital stay did not differ significantly
between the conventional treatment group and the fast
track group.
Our study was observational, investigating the effect of
introducing fast track care as a quality improvement
measure. This entailed that the patients did not follow a
rigorous study protocol. We do not know exactly how
many patients were admitted via the fast track admission
pathway, but the data on admission time would suggest
that this was the case for only about half of the patients.
Thus, the relatively high percentage of patients who
were not “fast tracked” to the orthopaedic ward may
have contributed to not finding a statistically significant
effect of fast track care on mortality. However, the
importance of admission time for postoperative outcome
is still controversial with shorter admission time being
associated with higher in-hospital mortality in one study
[28] and with fewer postoperative complications in
another [13]. The effect of preoperative waiting time on
postoperative outcome is not unequivocal either [29].
However, an increasing body of evidence suggests that a







% (95% CI b) % (95% CI b) % (95% CI b)
30-day mortality 7.9 (6.4 to 9.7) 6.5 (5.1 to 8.1) −1.4 (−3.7 to 0.9)
90-day mortality 13.5 (11.5 to 15.7) 12.5 (10.6 to 14.5) −1.0 (−3.9 to 1.8)
1-year mortality 22.8 (20.4 to 25.5) 22.8 (20.4 to 25.4) 0 (− 3.6 to 3.5)
aNumber of patients in group
b95% confidence interval
Table 4 Independent predictors of mortality
30-day mortality 90-day mortality 1-year mortality
Odds ratio (95% CIa) p-value Odds ratio (95% CIa) p-value Odds ratio (95% CIa) p-value
Age (years) 1.05 (1.03–1.07) < 0.0001 1.05 (1.03–1.07) < 0.0001 1.04 (1.03–1.05) < 0.0001
Male gender 2.08 (1.45–2.98) < 0.0001 1.91 (1.43–2.56) < 0.0001 1.73 (1.40–2.19) < 0.0001
Cognitive impairment uncertain 1.75 (1.03–2.96) 0.037 1.66 (1.09–2.54) 0.018 1.45 (1.02–2.06) 0.037
Cognitive impairment 2.86 (1.95–4.19) < 0.0001 3.03 (2.24–4.09) < 0.0001 2.56 (1.99–3.29) < 0.0001
ASAb-score 3.44 (2.54–4.65) < 0.0001 3.34 (2.61–4.26) < 0.0001 3.09 (2.53–3.77) < 0.0001
Logistic regression; 8.0% missing
a95% confidence interval
bAmerican Society of Anaesthesiologists
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[4, 30], risk of infection [31] and other complications [32].
Thus, the rather modest reduction in time to surgery of
just over two hours in the fast track group compared to
the conventional treatment group might have contributed
to not finding a statistically significant effect of fast track
care on mortality. However, time to surgery was not an
independent predictor of mortality in our cohort.
Our sample size calculation was based on our institu-
tion’s 30-day mortality rate in 2011. However, 30-day
mortality decreased considerably in 2012 and 2013, be-
fore fast track care was introduced, and subsequently
levelled off. Thus, our sample size calculation was based
on a higher mortality rate in the conventional treatment
group than we did observe, which would have made it
difficult to detect a possible effect of fast track care on
mortality. What caused this improvement is unclear.
The preparations to introduce fast track care started in
2012 and one could speculate that the increased focus
on hip fracture patients may have had a positive effect
already before fast track care was taken into practice.
Another possible scenario is that the introduction of fast
track care had a negative effect and interrupted a
positive time trend of decreasing mortality. However,
this seems less likely since the 30-day mortality levelled
off at a value that lies in the lower range of reported
rates [1–4].
One also has to consider the possibility that the con-
tinuous improvement of in-hospital hip fracture care has
resulted in mortality rates for this frail group of patients
which become increasingly difficult to reduce. This
notion seems to be supported by the fact that also other
recent approaches to improve hip fracture care, such as
geriatric co-management, had mixed results with some
studies reporting a statistically significant effect on
mortality [33, 34] while other studies did not [35, 36]. A
recent Cochrane review was not quite conclusive
concerning mortality, but stated that comprehensive
geriatric assessment probably reduces mortality in older
people with hip fracture (risk ratio 0.85, 95% CI 0.68 to
1.05; 5 trials, 1316 participants, inconsistency (I2) = 0%;
moderate-certainty evidence) [37]. While in-hospital
care is undoubtedly a cornerstone of hip fracture treat-
ment, improvements in rehabilitation in the primary
health care sector might also be warranted [19].
Fig. 2 Decrease in 30-day mortality before introduction of fast track care. a from Helgeland J et al. 2013 [26]
Table 5 Secondary outcome measures
Conventional treatment group (na = 1090) Fast track group (na = 1140) Between group difference
% (95% CI b) % (95% CI b) % (95% CI b)
Any cause reoperation 30 days 1.7 (1.1 to 2.7)¥ 0.6 (0.2 to 1.3)¥ −1.1 (− 2.2 to − 0.03)
Any cause reoperation 1 year 5.8 (4.5 to 7.3) 4.3 (3.2 to 5.6) − 1.5 (− 3.4 to 0.5)
Surgical site infection 30 daysc 2.5 (1.6 to 3.7) 1.8 (1.0 to 2.8) −0.7 (− 2.2 to 0.7)
Surgical site infection 1 yearc, d 3.0 (2.0 to 4.4) 2.0 (1.2 to 3.1) −1.0 (− 2.7 to 0.5)
Composite 30-day outcome 10.7 (9.0 to 12.7)# 8.1 (6.6 to 9.8)# −2.6 (−5.3 to −0.06)
30-day readmission 12.8 (10.9 to 15.0) 11.7 (9.9 to 13.7) −1.1 (−4.0 to 1.6)
aNumber of patients in group
b95% confidence interval
cData available for hemiarthroplasty, total hip arthroplasty and sliding hip screws
dSliding hip screws only followed up for infection for 30 days
¥Statistically significant difference in unadjusted (Fisher’s exact test, p = 0.017) and adjusted analysis (binary logistic regression) (odds ratio = 0.35 (95% CI: 0.15–0.84),
p = 0.019, 0% missing)
#Statistically significant difference in unadjusted analysis (Fisher’s exact test, p = 0.006)
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Our findings are in agreement with several other studies
of fast track care systems for hip fracture patients that
found no effect on mortality [14–17, 19]. While Eriksson
et al. [14], Larsson et al. [16] and Hansson et al. [19]
focused on bypassing the A&E department to reduce time
to surgery, Haugan et al. [17] reported on a more compre-
hensive fast track system, comparable to the one described
in our study. Using a retrospective study design they com-
pared a cohort of 788 hip fracture patients treated before
to 1032 patients treated after the introduction of fast track
care and found no difference in 30-day, 90-day or 1 year
mortality. In contrast, Pedersen et al. [18], who retrospect-
ively investigated a similar fast track system, found a sig-
nificantly lower 1-year mortality rate in their fast track
group (12 versus 23%) when looking at the subgroup of
community dwelling patients. This reduction in mortality
is quite pronounced and the reason for this apparent dis-
crepancy with our and the above mentioned findings is
unclear. The study by Pedersen et al. [18] was based on a
retrospective chart review. However, the intervention
group was defined by time period and mortality data was
obtained from the Civil Registration Office leaving little
room for error. Another conceivable explanation for a
potentially spurious positive finding by Pedersen et al.
may be their relatively small sample size. Their cohort
comprised 553 patients of which 376 were community
dwellers compared to a total of 1820 patients in the report
by Haugan et al. [17] and 2230 patients in this paper.
Information on prefracture living arrangements was not
available in our study. However, we performed a subgroup
analysis of healthier patients, who can be expected to live
in the community, and found no statistically significant ef-
fect of fast track care on mortality.
The presented study has several strengths. This study
is, to our knowledge, the largest to date investigating fast
track care for hip fracture patients. There was no loss to
follow-up concerning the main outcome measure of
mortality. The wide inclusion criteria imply that the
study population was representative and that the results
thus can be generalized.
Furthermore, this study is based on high quality data.
The NHFR records its data prospectively. In addition,
the data from the NHFR were cross referenced with data
from the electronic hospital records thereby further
increasing the data quality.
The study also has limitations. Data from the elec-
tronic hospital records were acquired retrospectively. It
is not possible to discriminate the effects of the different
components of the described fast track care system. Data
on admission time suggests that only about half of all
patients in the fast track group were admitted via the
fast track admission pathway. However, the expedient
admission is only one of several components of a fast
track hip fracture care system. There were small, but
due to the large number of patients, statistically signifi-
cant differences between the groups in several of the
baseline characteristics. However, in the multivariate
logistic regression analyses these differences were ad-
justed for. During the study period, 11% of all primary
hip fracture operations at our institution were not
reported to the NHFR. However, with a reporting rate of
87.9% before and 90.8% after the introduction of fast
track hip fracture care we consider it reasonable to
assume that the reporting practice remained largely
unchanged throughout the study. The reporting rate of
reoperations to the NHFR is inferior to the reporting
rate of primary operations [24]. Nevertheless, there is no
reason to believe that the reporting rate of reoperations
changed during the study period. Thus, the crude
number of reoperations is probably higher than reported
in this study, but the risk differences between the groups
of patients studied should not be influenced by
under-reporting of reoperations in only one of the
groups. While surgical site infections after hemiarthro-
plasty and total arthroplasty of the hip were followed up
after 30 days and one year, sliding hip screws were only
followed up after 30 days and internal fixations of
femoral neck fractures and intramedullary nails were not
followed up for this complication. However, this proced-
ure specific difference in follow-up for surgical site
infection applies equally to both the conventional
treatment group and the fast track group.
Since this study is based on register data it is not
possible to determine to what extent an individual





nb Median (IQ-rangec) nb Median (IQ-rangec)
Admission time (hours) 1053 3.9 (2.9–5.2)* 1061 1.1 (0.6–3.2)*
Time to surgery (hours) 1054 25.7 (18.9–39.7)# 1072 23.6 (18.0–32.6)#
Length of stay (days) 1054 5.3 (4.0–7.0) 1072 5.2 (4.0–7.3)
aNumber of patients in group
bNumber of patients with available data
cInterquartile range
*Statistically significant difference (Mann Whitney U test, p < 0.0001)
#Statistically significant difference (Mann Whitney U test, p < 0.0001)
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patient received treatment according to the department’s
fast track hip fracture care guidelines. However, while
the inclusion in a clinical trial will in itself influence any
outcome measure [38] this is not the case for this regis-
ter based study. The presented data thus reflect the
effect on mortality and the secondary outcome measures
one can expect by introducing a fast track hip fracture
care system similar to the one described as a quality
improvement measure.
We observed no increase in complications or read-
missions after the introduction of fast track care which
seems to indicate that “fast tracking” hip fracture pa-
tients to the orthopaedic ward after triage by trained
health care personnel is safe. Even though fast track
care did not significantly change mortality in this study,
there was a numerical trend to improvement for all
outcome measures and fast track care for hip fracture
patients is still in place at our institution. Efforts to
further improve hip fracture care should probably focus
on even shorter preoperative waiting times [4] in
combination with a fast track care system, geriatric
co-management [37] and intensified rehabilitation after
hospital discharge [19].
Conclusions
Fast track hip fracture care is safe. However, we
observed no statistically significant change in 30-day,
90-day or 1-year mortality after the introduction of fast
track hip fracture care.
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